CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6959 result(s)

Agalsidase beta (Fabrazyme)

Last Updated: December 10, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Agalsidase beta
Indications: Fabry Disease

  • Brand Name: Fabrazyme
  • Manufacturer: Genzyme Canada
  • Project Number: S0028
  • Project Status: Complete
  • Submission Type: Resubmission

Ximelagatran in prevention of cardiovascular events

Last Updated: November 25, 2004
Result type: Reports

Ximelagatran (Exanta®) is the first oral anticoagulant in a new class of drugs called direct thrombin inhibitors. Two studies suggest that ximelagatran is at least as effective as warfarin in preventing stroke in high risk patients with atrial fibrillation. Ximelagatran may also reduce the rate of major cardiovascular events after a myocardia...

Alefacept (Amevive)

Last Updated: November 16, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Alefacept
Indications: Psoriasis, moderate to severe chronic plaque

  • Brand Name: Amevive
  • Manufacturer: Biogen Idec Canada Inc.
  • Project Number: S0024
  • Project Status: Complete
  • Submission Type: New

Voriconazole (VFEND)

Last Updated: October 25, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Voriconazole
Indications: Aspergillosis, Invasive

  • Brand Name: VFEND
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: S0023
  • Project Status: Complete
  • Submission Type: Resubmission

Adalimumab (Humira)

Last Updated: September 24, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Adalimumab
Indications: Arthritis, Rheumatoid

  • Brand Name: Humira
  • Manufacturer: Abbott Laboratories Limited
  • Project Number: S0022
  • Project Status: Complete
  • Submission Type: New

Eletriptan hydrobromide (Relpax)

Last Updated: September 21, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Eletriptan hydrobromide
Indications: Migraine

  • Brand Name: Relpax
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: S0021
  • Project Status: Complete
  • Submission Type: New